Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | KAZ954 |
Synonyms | |
Therapy Description |
KAZ954 is a monoclonal antibody targeting ectonucleoside triphosphate diphosphohydrolase (ENTPD2), which inhibits the hydrolysis of ATP to ADP and potentially induces antibody-dependent cell-mediated cytotoxicity (ADCC) and inhibition of tumor growth (Mol Cancer Ther (2023) 22 (12_Supplement): PR015). |